Both in Pharmaceuticals
Onconetix vs Cadrenal Therapeutics
Over the past year ONCO returned −99.6% and CVKD returned −91.2%; their daily moves had a correlation of 0.03.
ONCO −99.6% CVKD −91.2%Growth of $1, one year, split-adjusted
| Metric | ONCO | CVKD |
|---|---|---|
| Price | $0.6583 | $1.06 |
| Market cap | $3.9M | $3.8M |
| Today | +15.69% | −6.19% |
| 1 month | −0.4% | +7.1% |
| 6 months | −85.4% | −82.8% |
| Year to date | −99.2% | −84.4% |
| 1 year | −99.6% | −92.1% |
| Revenue growth (YoY) | −83.9% | — |
| Gross margin | 25.1% | — |
| Net margin | −16748.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.0× | — |
| Net cash | $5.8M | $2.4M |
| Dividend yield | — | — |
| Volatility (60d) | 159.7% | 90.3% |
| Short % of float | 7.4% | 9.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).